Is Ambiq the Answer to AI’s Biggest Blind Spot?
AI might be the future, but that future has a power problem. For all the fanfare surrounding generative AI, one inconvenient truth continues to lurk in the background, which is it consumes an extraordinary amount of energy.
And unless someone cracks the code on power efficiency, scaling AI beyond the data center and into billions of edge devices will remain an expensive dream.
» Read more about: Is Ambiq the Answer to AI’s Biggest Blind Spot? »
Read More
Wall Street’s Favorite Sleeper in the AI Infrastructure Boom?
Data streaming might sound like a back-office technology, the kind of thing only engineers care about, but it’s quickly becoming a foundational pillar of the digital world. And while most investors are busy chasing flashy AI stocks, one lesser-known name sits quietly at the heart of this infrastructure shift, Confluent (NASDAQ: CFLT).
» Read more about: Wall Street’s Favorite Sleeper in the AI Infrastructure Boom? »
Read More
Will This ETF 2x Before Year End?
In recent months, some of the most sophisticated investors on Wall Street have made a bold move by pouring hundreds of millions into BlackRock’s iShares Bitcoin Trust (IBIT).
This isn’t just a passing trade but a conviction bet that Bitcoin’s best days may still be ahead and while still trading under $100,000 per coin,
» Read more about: Will This ETF 2x Before Year End? »
Read More
Could Meta Be the Next $2 Trillion Titan?
With over 3.4 billion people engaging with at least one of Meta’s apps daily, the company already owns the world’s largest digital attention network. But now, it’s not just about scale, it’s about intelligence. Meta has embedded AI deep into its core product experiences, reshaping how users interact with content and how advertisers connect with audiences.
» Read more about: Could Meta Be the Next $2 Trillion Titan? »
Read More
Is Buffett’s Favorite Stock Finally a Buy?
Berkshire Hathaway (NYSE: BRK.B) has dipped from its record highs earlier this year, and the pullback has some investors wondering: Is this the beginning of something more serious or a golden opportunity in disguise?
With shares of the B class now trading below the $490 mark, the question becomes not whether the stock is cheap in a traditional sense,
» Read more about: Is Buffett’s Favorite Stock Finally a Buy? »
Read MoreThe Burst
How a $300 Mistake Opened a $1 Billion Market
Novo Nordisk, the pharmaceutical giant behind weight-loss blockbusters Ozempic and Wegovy, just let a key patent on semaglutide lapse in Canada because it forgot to pay a routine maintenance fee, the pharmaceutical equivalent of forgetting to renew your car registration.
As a result, generic versions of semaglutide, the active ingredient in both drugs,
» Read more about: How a $300 Mistake Opened a $1 Billion Market »
Read MoreThe Spotlight
Will This AI Goliath Hit $4 Trillion by 2027?
While no company has reached that towering $4 trillion milestone yet, Microsoft, Apple, and Nvidia are all within striking distance.
It’s not inconceivable that any one of them could be first past the post but if you’re asking who not only gets there, but stays there, the strongest case can be made for Microsoft.
» Read more about: Will This AI Goliath Hit $4 Trillion by 2027? »
Read MoreThe Daily
Just 1 Stock Market Sector Now Makes Up 34% of the S&P 500. Here's What It Means for Your Investment Portfolio.
A handful of companies are driving the S&P 500’s push to all-time highs, but risks remain.
The S&P 500 closed Sept. 12 up 12% year to date, 62% over the last three years, and 97% over the last five years. Mega-cap growth-focused companies are largely responsible for driving the index to new heights.